These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37164214)

  • 21. Medical care costs associated with progression of diabetic nephropathy.
    Nichols GA; Vupputuri S; Lau H
    Diabetes Care; 2011 Nov; 34(11):2374-8. PubMed ID: 22025783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased serum extracellular superoxide dismutase activity is associated with albuminuria in Chinese patients with type 2 diabetes mellitus.
    Feng G; Gao JL; Zhang P; Huang JJ; Huang LZ; Cheng L; Pu C
    Acta Diabetol; 2017 Nov; 54(11):1047-1055. PubMed ID: 28894973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study.
    Rossing P; Hougaard P; Parving HH
    Diabetes Care; 2002 May; 25(5):859-64. PubMed ID: 11978681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The early natural history of albuminuria in young adults with youth-onset type 1 and type 2 diabetes.
    Kahkoska AR; Isom S; Divers J; Mayer-Davis EJ; Dolan L; Shah AS; Afkarian M; Pettitt DJ; Lawrence JM; Marcovina S; Saydah SH; Dabelea D; Maahs DM; Mottl AK;
    J Diabetes Complications; 2018 Dec; 32(12):1160-1168. PubMed ID: 30316542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes.
    Park JY; Kim HK; Chung YE; Kim SW; Hong SK; Lee KU
    Diabetes Care; 1998 Apr; 21(4):530-4. PubMed ID: 9571337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients.
    Torffvit O; Agardh CD
    J Diabetes Complications; 2001; 15(6):307-13. PubMed ID: 11711324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with progression of diabetic nephropathy in Japanese elderly patients with type 2 diabetes: sub-analysis of the Japanese Elderly Diabetes Intervention Trial.
    Araki S; Nishio Y; Araki A; Umegaki H; Sakurai T; Iimuro S; Ohashi Y; Uzu T; Maegawa H; Kashiwagi A; Ito H;
    Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():127-33. PubMed ID: 22435948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher levels of physical activity are independently associated with a lower incidence of diabetic retinopathy in Japanese patients with type 2 diabetes: A prospective cohort study, Diabetes Distress and Care Registry at Tenri (DDCRT15).
    Kuwata H; Okamura S; Hayashino Y; Tsujii S; Ishii H;
    PLoS One; 2017; 12(3):e0172890. PubMed ID: 28257419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Albuminuria in the diabetic patient: practical management].
    Kistler AD
    Praxis (Bern 1994); 2013 Oct; 102(20):1229-35. PubMed ID: 24088233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014.
    Kume S; Araki SI; Ugi S; Morino K; Koya D; Nishio Y; Haneda M; Kashiwagi A; Maegawa H
    J Diabetes Investig; 2019 Jul; 10(4):1032-1040. PubMed ID: 30451386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study.
    Lindhardt M; Persson F; Zürbig P; Stalmach A; Mischak H; de Zeeuw D; Lambers Heerspink H; Klein R; Orchard T; Porta M; Fuller J; Bilous R; Chaturvedi N; Parving HH; Rossing P
    Nephrol Dial Transplant; 2017 Nov; 32(11):1866-1873. PubMed ID: 27507891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microalbuminuria prevalence study in hypertensive type 2 diabetic patients in Malaysia.
    Kong NC; Chia YC; Khalid BA; Juwita S; Samiah Yasmin AK; Yap LY; Norlaila M; Menon J; Tan C; Fung YK;
    Med J Malaysia; 2006 Oct; 61(4):457-65. PubMed ID: 17243524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study).
    Kinguchi S; Wakui H; Ito Y; Kondo Y; Azushima K; Osada U; Yamakawa T; Iwamoto T; Yutoh J; Misumi T; Aoki K; Yasuda G; Yoshii T; Yamada T; Ono S; Shibasaki-Kurita T; Hosokawa S; Orime K; Hanaoka M; Sasaki H; Inazumi K; Yamada T; Kobayashi R; Ohki K; Haruhara K; Kobayashi Y; Yamanaka T; Terauchi Y; Tamura K
    Cardiovasc Diabetol; 2019 Aug; 18(1):110. PubMed ID: 31455298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study.
    Gall MA; Hougaard P; Borch-Johnsen K; Parving HH
    BMJ; 1997 Mar; 314(7083):783-8. PubMed ID: 9080995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
    van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
    Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study.
    Böger CA; Haak T; Götz AK; Christ J; Ruff E; Hoffmann U; Riegger GA; Krämer BK
    Int J Clin Pharmacol Ther; 2006 Aug; 44(8):364-74. PubMed ID: 16961167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study.
    Moriya T; Tanaka S; Kawasaki R; Ohashi Y; Akanuma Y; Yamada N; Sone H; Yamashita H; Katayama S;
    Diabetes Care; 2013 Sep; 36(9):2803-9. PubMed ID: 23620478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.